These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
442 related articles for article (PubMed ID: 1554008)
1. Draft guidelines on quality assurance for pharmacy-prepared sterile products. Am J Hosp Pharm; 1992 Feb; 49(2):407-17. PubMed ID: 1554008 [No Abstract] [Full Text] [Related]
2. Draft technical assistance bulletin on quality assurance for pharmacy-prepared sterile products. American Society of Hospital Pharmacists, Council on Professional Affairs. Am J Hosp Pharm; 1993 Jul; 50(7):1440-52. PubMed ID: 8362882 [No Abstract] [Full Text] [Related]
4. The potential impact of usp general chapter <797> on procedures and requirements for the preparation of sterile radiopharmaceuticals. Hung JC J Nucl Med; 2004 Jun; 45(6):21N-6N. PubMed ID: 15181115 [No Abstract] [Full Text] [Related]
5. Draft guidelines on compounding of nonsterile products in pharmacies. American Society of Hospital Pharmacists. Am J Hosp Pharm; 1993 Jul; 50(7):1452-61. PubMed ID: 8362883 [No Abstract] [Full Text] [Related]
6. National survey of quality assurance activities for pharmacy-prepared sterile products in hospitals. Crawford SY; Narducci WA; Augustine SC Am J Hosp Pharm; 1991 Nov; 48(11):2398-413. PubMed ID: 1746573 [TBL] [Abstract][Full Text] [Related]
7. Quality assurance to quality improvement: measuring and monitoring pharmaceutical care. Angaran DM Am J Hosp Pharm; 1991 Sep; 48(9):1901-7. PubMed ID: 1928130 [No Abstract] [Full Text] [Related]
8. ASHP technical assistance bulletin on quality assurance for pharmacy-prepared sterile products. Am J Hosp Pharm; 1993 Nov; 50(11):2386-98. PubMed ID: 8266973 [No Abstract] [Full Text] [Related]
9. Joint Commission expectations related to USP-NF Chapter 797 on compounding sterile preparations. Jt Comm Perspect; 2006 Apr; 26(4):5. PubMed ID: 16786622 [No Abstract] [Full Text] [Related]
10. Reporting drug product defects--JCAHO. Hoffmann RP Hosp Pharm; 1989 Feb; 24(2):143-4. PubMed ID: 10318199 [No Abstract] [Full Text] [Related]
11. Pharmacists' opinions about and compliance with recommendations for intravenous admixture practices. Brzozowski DF; Hale KM; Segal R; Mirtallo JM Am J Hosp Pharm; 1987 Sep; 44(9):2077-84. PubMed ID: 3479020 [TBL] [Abstract][Full Text] [Related]
12. Time limit on multidose vials after initial entry. Moi S; Thornton JP Hosp Pharm; 1991 Sep; 26(9):805, 809. PubMed ID: 10114012 [No Abstract] [Full Text] [Related]
13. Upgrading quality assurance for pharmacy-prepared sterile products. Zellmer WA Am J Hosp Pharm; 1991 Nov; 48(11):2387-8. PubMed ID: 1746571 [No Abstract] [Full Text] [Related]
14. Joint Commission charts new course for quality assurance. O'Leary D Am J Hosp Pharm; 1986 Oct; 43(10):2403. PubMed ID: 3466535 [No Abstract] [Full Text] [Related]
15. Survey of sterile product compounding practices in Canadian hospital pharmacies. Fitch DP; Hall KW Can J Hosp Pharm; 1993 Dec; 46(6):249-60. PubMed ID: 10131343 [TBL] [Abstract][Full Text] [Related]
18. [Bacteriological quality of air in a ward for sterile pharmaceutical preparations]. Caorsi P B; Sakurada Z A; Ulloa F MT; Pezzani V M; Latorre O P Rev Chilena Infectol; 2011 Feb; 28(1):14-8. PubMed ID: 21526280 [TBL] [Abstract][Full Text] [Related]
19. ASHP guidelines on compounding sterile preparations. American Society of Health System Pharmacists Am J Health Syst Pharm; 2014 Jan; 71(2):145-66. PubMed ID: 24375608 [No Abstract] [Full Text] [Related]
20. Accreditation standard for pharmacy residency in a hospital with guide to interpretation. Am J Hosp Pharm; 1975 Feb; 32(2):192-8. PubMed ID: 1136965 [No Abstract] [Full Text] [Related] [Next] [New Search]